Session Information
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer in Singapore
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
All times listed are in Singapore time (GMT+8)
PL - Plenary
PS - Presidential Symposium
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
IS - Industry Symposium
JICC - Joint IASLC-CAALC-CSCO Session
January 28 Thu
Jan 28 Friday
January 29 Fri
Jan 29 Saturday
January 30 Sat
Jan 30 Sunday
January 31 Sun
Jan 31
-
+
ES11 - Practice Changing Initiatives
- 09:15 - 10:45
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Nursing and Allied Health Professionals
-
+
ES11.01 - Chair
09:15 - 09:15 | Presenter: Maria Ftanou
- Abstract
No abstract available for this presentation
-
+
ES11.02 - Chair
09:15 - 09:15 | Presenter: Anne Fraser
- Abstract
No abstract available for this presentation
-
+
ES11.03 - Managing the Psychological Needs of Patients in a Screening Service
09:15 - 09:27 | Presenter: Lisa Burgess
- Abstract
Loading... -
+
ES11.04 - Assessment of Physical Function in Patients Undergoing Lung-sparing Surgery for Malignant Pleural Mesothelioma
09:27 - 09:39 | Presenter: Simon Ho
- Abstract
Loading... -
+
ES11.05 - Effect of Qigong on Symptom Management of Lung Cancer Patients
09:39 - 09:51 | Presenter: Shirley Siu-yin Ching
- Abstract
No abstract available for this presentation
-
+
ES11.06 - Developing a Care Board
09:51 - 10:03 | Presenter: Manuela Eicher
- Abstract
Loading... -
+
ES11.07 - Preoperative Exercise Training for Patients with Non-Small Cell Lung Cancer
10:03 - 10:18 | Presenter: Catherine Granger
- Abstract
No abstract available for this presentation
-
+
ES11.08 - Live Q&A
10:18 - 10:43
- Abstract
No abstract available for this presentation
-
+
ES12 - Public Health Issues in Lung Cancer Screening
- 10:30 - 11:30
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Screening and Early Detection
-
+
ES12.01 - Patient Perspective on Lung Cancer Screening and Health Disparities
10:30 - 10:45 | Presenter: Andrea Borondy-Kitts
- Abstract
Loading... -
+
ES12.02 - Defining High Risk
10:45 - 11:00 | Presenter: Martin Carl Tammemagi
- Abstract
Loading... -
+
ES12.03 - Screening in Indigenous Maori Population
11:00 - 11:15 | Presenter: Sue Crengle
- Abstract
No abstract available for this presentation
-
+
ES12.04 - Mobile CT and Effective Screening for Underserved Populations
11:15 - 11:30 | Presenter: Carlijn van der Aalst
- Abstract
No abstract available for this presentation
-
+
OA07 - Immuno-biology and Novel Immunotherapeutics from Bench to Bed
- 10:30 - 11:30
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
-
+
OA07.01 - Chair
10:30 - 10:30 | Presenter: Jyoti D Patel
- Abstract
No abstract available for this presentation
-
+
OA07.02 - Chair
10:30 - 10:30 | Presenter: Aaron Lisberg
- Abstract
No abstract available for this presentation
-
+
OA07.03 - Comutations in DDR Pathways Predict Atezolizumab Response in Non-Small Cell Lung Cancer Patients
10:30 - 10:40 | Presenter: Wei Nie
- Abstract
Loading... -
+
OA07.04 - LKB1 Deficiency Leads to an “Adenosine-Rich” Tumor Microenvironment by Recruiting Myeloid-Derived Suppressive Cells
10:40 - 10:50 | Presenter: Xue Bai
- Abstract
Loading... -
+
OA07.05 - Discussant
10:50 - 10:55 | Presenter: Myung-Ju Ahn
- Abstract
No abstract available for this presentation
-
+
OA07.06 - Interdependence of KRAS and TP53 Mutations in Predicting ICI Efficacy in EGFR/ALKWT Non-Squamous NSCLC: Results From 1129 Patient-Level Data
10:55 - 11:00 | Presenter: Lin Li
- Abstract
Loading... -
+
OA07.07 - PARP1 Inhibitors Enhanced IFNγ-Induced PD-L1 Expression in LKB1-Mutant Lung Cancer
11:00 - 11:05 | Presenter: Xue Bai
- Abstract
Loading... -
+
OA07.08 - HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed, Phase II Platform Study in Patients with NSCLC, who Progressed on Anti-PD(L)1 Therapy
11:05 - 11:10 | Presenter: Benjamin Besse
- Abstract
Loading... -
+
OA07.09 - Sintilimab in Combination with Anlotinib as First-Line Therapy for Advanced NSCLC: Final Analysis of Primary Endpoints
11:10 - 11:15 | Presenter: Baohui Han
- Abstract
Loading... -
+
OA07.10 - Discussant
11:15 - 11:20 | Presenter: Laura Mezquita
- Abstract
No abstract available for this presentation
-
+
OA07.11 - Live Q&A
11:20 - 11:30
- Abstract
No abstract available for this presentation
-
+
ES14 - Novel Immunotherapy Strategies in NSCLC
- 11:45 - 12:45
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
-
+
ES14.02 - Cellular Therapies in NSCLC
11:45 - 11:57 | Presenter: Melissa L Johnson
- Abstract
Loading... -
+
ES14.03 - Combining Epigenetic Therapy and Immunotherapy in NSCLC
11:57 - 12:09 | Presenter: Julie Brahmer
- Abstract
No abstract available for this presentation
-
+
ES14.04 - Combining Immunotherapy and Anti-Angiogenic Agents
12:09 - 12:21 | Presenter: Enriqueta Felip
- Abstract
No abstract available for this presentation
-
+
ES14.05 - Combining Targeted Therapies With Immunotherapy
12:21 - 12:33 | Presenter: Daniel SW Tan
- Abstract
No abstract available for this presentation
-
+
ES14.06 - Novel Immunotherapy Targets in NSCLC
12:33 - 12:45 | Presenter: Jie Wang
- Abstract
No abstract available for this presentation
-
+
MA05 - Lung Cancer Screening
- 11:45 - 12:45
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Screening and Early Detection
-
+
MA05.01 - Chair
11:45 - 11:45 | Presenter: Chong Kin Liam
- Abstract
No abstract available for this presentation
-
+
MA05.02 - Chair
11:45 - 11:45 | Presenter: Jacob Sands
- Abstract
No abstract available for this presentation
-
+
MA05.03 - Differential Frequency of Blood Immune Cells as Biomarkers for Risks Assessment in bioMILD Lung Cancer Screening Trial
11:45 - 11:50 | Presenter: Gabriella Sozzi
- Abstract
Loading... -
+
MA05.04 - Why are Lung Cancer Detection Rates Higher in the Manchester Lung Health Checks than in the National Lung Screening Trial?
11:50 - 11:55 | Presenter: Hilary A Robbins
- Abstract
Loading... -
+
MA05.05 - Low-Dose Chest Computed Tomographic Screening and Invasive Diagnosis of Pulmonary Nodules for Lung Cancer in Never-Smokers
11:55 - 12:00 | Presenter: Yeon Wook Kim
- Abstract
Loading... -
+
MA05.06 - Lung Cancer Screening – Cumulative Results from Five UK-Based Programmes
12:00 - 12:05 | Presenter: Haval Balata
- Abstract
Loading... -
+
MA05.07 - Discussant
12:05 - 12:10 | Presenter: Stephen Lam
- Abstract
No abstract available for this presentation
-
+
MA05.08 - Impact of Low-Dose CT Screening for Primary Lung Cancer on Subsequent Risk of Brain Metastasis: Secondary Analysis of NLST
12:10 - 12:15 | Presenter: Chloe Chang Su
- Abstract
Loading... -
+
MA05.09 - Evaluation of Alternative Diagnostic Follow-Up Intervals for Lung-RADs Criteria on the Effectiveness of Lung Cancer Screening
12:15 - 12:20 | Presenter: Mehrad Bastani
- Abstract
Loading... -
+
MA05.10 - Performance of Draft 2020 USPSTF Lung-Cancer Screening Guidelines and Potential for use of Risk Models to Reduce Racial/Ethnic Disparities
12:20 - 12:25 | Presenter: Rebecca Landy
- Abstract
Loading... -
+
MA05.11 - Effect of Lowering the Starting Age for Lung Cancer Screening by Low-Dose Computed Tomography Among Women: A Harm-Benefit Analysis
12:25 - 12:30 | Presenter: Yihui Du
- Abstract
Loading... -
+
MA05.12 - Discussant
12:30 - 12:35 | Presenter: Hui Zhong Chai
- Abstract
No abstract available for this presentation
-
+
MA05.13 - Live Q&A
12:35 - 12:45
- Abstract
No abstract available for this presentation
-
+
OA08 - Putting the Patient at the Center: Holistic Patient Care
- 11:45 - 12:45
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Nursing and Allied Health Professionals
-
+
OA08.01 - Chair
11:45 - 11:45 | Presenter: Csaba Laszlo Degi
- Abstract
No abstract available for this presentation
-
+
OA08.02 - Chair
11:45 - 11:45 | Presenter: Yeur-Hur Lai
- Abstract
No abstract available for this presentation
-
+
OA08.03 - Joint Modeling of Stress and Survival in Patients with Advanced Non-Small Cell Lung Cancer
11:45 - 11:55 | Presenter: Nicole Andrea Arrato
- Abstract
Loading... -
+
OA08.04 - Providing Thoracic Prehabilitation during COVID-19: Review of a Virtual Model
11:55 - 12:05 | Presenter: Stephanie Wynne
- Abstract
Loading... -
+
OA08.05 - Illness Perception Profiles at Lung Cancer Diagnosis and Physical and Psychological Symptom Trajectories During Treatment
12:05 - 12:15 | Presenter: Thomas Robert Valentine
- Abstract
Loading... -
+
OA08.06 - How Complex is Fatigue? Occupational Therapy Playing a Lead Role in Fatigue Management
12:15 - 12:25 | Presenter: Pippa Labuc
- Abstract
Loading... -
+
OA08.07 - Discussant
12:25 - 12:35 | Presenter: Andreas Charalambous
- Abstract
No abstract available for this presentation
-
+
OA08.08 - Live Q&A
12:35 - 12:45
- Abstract
No abstract available for this presentation
-
+
IS11 - Industry Symposium Sponsored by Amgen Oncology: Advancing the Next Frontier of Innovation in Lung Cancer Therapies
- 13:00 - 14:00
- 1/30/2021
- Location: Industry Symposia Auditorium (via Industry Hub)
- Not for CME Credit
- Type: Industry Symposium
- Track:
-
+
IS11.01 - Introductions
13:00 - 13:00
- Abstract
No abstract available for this presentation
-
+
IS11.02 - Current Biomarker Landscape in NSCLC
13:00 - 13:20 | Presenter: Stephen Fox
- Abstract
No abstract available for this presentation
-
+
IS11.03 - Current Unmet Need in KRAS G12C-Mutated NSCLC
13:20 - 13:40 | Presenter: Koichi Goto
- Abstract
No abstract available for this presentation
-
+
IS11.04 - Emerging Novel Targets for Lung Cancer
13:40 - 14:00 | Presenter: Julie Brahmer
- Abstract
No abstract available for this presentation
-
+
IS12 - Industry Symposium Sponsored by: Boehringer Ingelheim: Know Your Patients With NSCLC
- 13:00 - 14:00
- 1/30/2021
- Location: Industry Symposia Auditorium (via Industry Hub)
- Not for CME Credit
- Type: Industry Symposium
- Track:
-
+
IS12.01 - Introduction
13:00 - 13:05 | Presenter: David R. Gandara
- Abstract
No abstract available for this presentation
-
+
IS12.02 - Know How to Test Your Patients
13:05 - 13:15 | Presenter: John R Gosney
- Abstract
No abstract available for this presentation
-
+
IS12.03 - Know How to Sequence EGFR TKIS
13:15 - 13:25 | Presenter: Barbara Melosky
- Abstract
No abstract available for this presentation
-
+
IS12.04 - Know Your Patients With Uncommon EGFR Mutations
13:25 - 13:35 | Presenter: Satoru Miura
- Abstract
No abstract available for this presentation
-
+
IS12.05 - What’s Next for Treatment of Advanced Stage Squamous NSCLC
13:35 - 13:45 | Presenter: David R. Gandara
- Abstract
No abstract available for this presentation
-
+
IS12.06 - Know What’s Next for Your Patients: Looking to the Future
13:45 - 13:55 | Presenter: David R. Gandara
- Abstract
No abstract available for this presentation
-
+
IS12.07 - Closing
13:55 - 14:00 | Presenter: David R. Gandara
- Abstract
No abstract available for this presentation
-
+
IS13 - Satellite CME Symposium by ACE Oncology: Hot Topics in the Management of Advanced Non-Small Cell Lung Cancer: Expert Insights on Recent Advances
- 13:00 - 14:00
- 1/30/2021
- Location: Scientific Program Auditorium
- CME Accredited by Other Provider
- Type: Satellite CME Symposia
- Track:
-
+
IS13.01 - Welcome, Introduction, and Interactive Quiz
13:00 - 13:05 | Presenter: Daniel SW Tan
- Abstract
No abstract available for this presentation
-
+
IS13.02 - When Is the Right Time to Use NGS-Based Liquid Biopsy in Advanced NSCLC?
13:05 - 13:20 | Presenter: Herbert H Loong
- Abstract
No abstract available for this presentation
-
+
IS13.03 - Integrating New Targeted Therapy for NSCLC With Rare Oncogenic Drivers Into Clinical Practice
13:20 - 13:35 | Presenter: Terufumi Kato
- Abstract
No abstract available for this presentation
-
+
IS13.04 - Enhancing Immune Checkpoint Inhibition With Bifunctional Antibodies
13:35 - 13:50 | Presenter: Daniel SW Tan
- Abstract
No abstract available for this presentation
-
+
IS13.05 - Quiz Questions Revisited and Q&A
13:50 - 13:59
- Abstract
No abstract available for this presentation
-
+
IS13.06 - Pearls for Practice
13:59 - 14:00 | Presenter: Daniel SW Tan
- Abstract
No abstract available for this presentation
-
+
ES15 - Getting All NSCLCs Genotyped: How Can We Get to 100%?
- 14:15 - 15:15
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
-
+
ES15.01 - Reflex Genotyping of Advanced NSCLC: The Benefits and the Barriers
14:15 - 14:30 | Presenter: Dara Aisner
- Abstract
No abstract available for this presentation
-
+
ES15.02 - Supplementing Tumor Genotyping with ctDNA Genotyping: What Is the Best Approach?
14:30 - 14:45 | Presenter: Fernando Lopez-Rios
- Abstract
No abstract available for this presentation
-
+
ES15.04 - Engaging Lung Cancer Patients in their Molecular Testing
14:45 - 15:00 | Presenter: Andrew Ciupek
- Abstract
Loading... -
+
ES15.05 - Effective and Interpretable Reporting of Genotyping Results
15:00 - 15:15 | Presenter: Stacy Wang Gray
- Abstract
Loading...